Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiotherapy Planning, Computer-Assisted | 120 | 2024 | 1679 | 15.970 |
Why?
|
Monte Carlo Method | 126 | 2024 | 1259 | 13.970 |
Why?
|
Relative Biological Effectiveness | 61 | 2024 | 313 | 11.390 |
Why?
|
Radiotherapy, Intensity-Modulated | 40 | 2024 | 798 | 8.910 |
Why?
|
Linear Energy Transfer | 38 | 2024 | 154 | 7.380 |
Why?
|
Protons | 55 | 2023 | 1113 | 7.220 |
Why?
|
Radiotherapy Dosage | 115 | 2024 | 2916 | 6.960 |
Why?
|
Radiometry | 52 | 2024 | 818 | 6.900 |
Why?
|
Organs at Risk | 31 | 2024 | 367 | 6.800 |
Why?
|
Photons | 28 | 2024 | 594 | 4.260 |
Why?
|
Neoplasms, Radiation-Induced | 15 | 2024 | 542 | 3.530 |
Why?
|
Neutrons | 12 | 2024 | 78 | 3.480 |
Why?
|
Phantoms, Imaging | 45 | 2024 | 2512 | 3.000 |
Why?
|
Neoplasms, Second Primary | 13 | 2020 | 1061 | 2.830 |
Why?
|
Scattering, Radiation | 25 | 2020 | 489 | 2.790 |
Why?
|
Radiation Dosage | 31 | 2024 | 1967 | 2.770 |
Why?
|
Uncertainty | 23 | 2023 | 769 | 2.730 |
Why?
|
Radiotherapy, Conformal | 12 | 2021 | 549 | 2.570 |
Why?
|
Models, Biological | 33 | 2024 | 9495 | 2.150 |
Why?
|
Radiation Injuries | 14 | 2024 | 1198 | 2.070 |
Why?
|
Radiotherapy | 18 | 2024 | 1502 | 2.030 |
Why?
|
Radiation Oncology | 12 | 2024 | 572 | 2.020 |
Why?
|
Neoplasms | 43 | 2024 | 22371 | 1.960 |
Why?
|
Radiobiology | 8 | 2020 | 89 | 1.900 |
Why?
|
Models, Theoretical | 20 | 2021 | 3573 | 1.880 |
Why?
|
Movement | 12 | 2019 | 1490 | 1.830 |
Why?
|
Algorithms | 44 | 2024 | 14164 | 1.730 |
Why?
|
Head and Neck Neoplasms | 19 | 2024 | 2931 | 1.710 |
Why?
|
Radiotherapy, High-Energy | 9 | 2015 | 228 | 1.700 |
Why?
|
Lung Neoplasms | 27 | 2023 | 13586 | 1.550 |
Why?
|
Radiotherapy, Computer-Assisted | 7 | 2015 | 90 | 1.530 |
Why?
|
Dose-Response Relationship, Radiation | 21 | 2018 | 876 | 1.510 |
Why?
|
Ependymoma | 5 | 2018 | 328 | 1.500 |
Why?
|
Necrosis | 4 | 2024 | 1616 | 1.270 |
Why?
|
Lymphopenia | 4 | 2023 | 300 | 1.250 |
Why?
|
Positron-Emission Tomography | 21 | 2017 | 6669 | 1.180 |
Why?
|
Liver Neoplasms | 12 | 2023 | 4362 | 1.060 |
Why?
|
Respiration | 9 | 2015 | 1665 | 1.050 |
Why?
|
Computer Simulation | 31 | 2024 | 6283 | 1.040 |
Why?
|
Metal Nanoparticles | 6 | 2021 | 406 | 0.990 |
Why?
|
Prostatic Neoplasms | 18 | 2022 | 11101 | 0.980 |
Why?
|
Radiation Monitoring | 3 | 2015 | 106 | 0.940 |
Why?
|
Brain Neoplasms | 14 | 2024 | 9118 | 0.930 |
Why?
|
DNA Damage | 12 | 2023 | 2469 | 0.890 |
Why?
|
Tomography, X-Ray Computed | 28 | 2024 | 20760 | 0.860 |
Why?
|
Four-Dimensional Computed Tomography | 4 | 2020 | 142 | 0.860 |
Why?
|
Humans | 218 | 2024 | 768166 | 0.850 |
Why?
|
Software | 13 | 2023 | 4478 | 0.850 |
Why?
|
Electrons | 8 | 2018 | 264 | 0.820 |
Why?
|
Radiation Pneumonitis | 2 | 2020 | 100 | 0.800 |
Why?
|
Radiation Tolerance | 9 | 2021 | 476 | 0.800 |
Why?
|
Models, Statistical | 18 | 2024 | 5107 | 0.790 |
Why?
|
Infratentorial Neoplasms | 3 | 2018 | 99 | 0.790 |
Why?
|
Microtechnology | 2 | 2019 | 70 | 0.780 |
Why?
|
DNA Repair | 10 | 2023 | 2050 | 0.770 |
Why?
|
Lung | 13 | 2021 | 10099 | 0.760 |
Why?
|
Brain Stem | 5 | 2018 | 859 | 0.750 |
Why?
|
Elementary Particles | 3 | 2010 | 50 | 0.740 |
Why?
|
Nanofibers | 1 | 2021 | 68 | 0.720 |
Why?
|
Artifacts | 6 | 2024 | 1926 | 0.720 |
Why?
|
Metals | 4 | 2024 | 713 | 0.710 |
Why?
|
Cell Survival | 15 | 2019 | 5777 | 0.710 |
Why?
|
Water | 12 | 2021 | 1421 | 0.700 |
Why?
|
Rib Fractures | 1 | 2020 | 124 | 0.620 |
Why?
|
Motion | 5 | 2015 | 790 | 0.620 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2023 | 5432 | 0.620 |
Why?
|
Radiation Protection | 6 | 2016 | 428 | 0.610 |
Why?
|
Radiosurgery | 5 | 2019 | 1330 | 0.610 |
Why?
|
Arteriovenous Malformations | 2 | 2019 | 396 | 0.560 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2023 | 2333 | 0.530 |
Why?
|
Skull Base Neoplasms | 2 | 2017 | 279 | 0.530 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2020 | 459 | 0.500 |
Why?
|
Reproducibility of Results | 24 | 2024 | 20227 | 0.480 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 590 | 0.480 |
Why?
|
Gamma Rays | 3 | 2017 | 319 | 0.470 |
Why?
|
Lymphocytes | 5 | 2023 | 2614 | 0.460 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 506 | 0.450 |
Why?
|
Gold | 5 | 2021 | 488 | 0.450 |
Why?
|
Equipment Failure Analysis | 3 | 2010 | 845 | 0.450 |
Why?
|
Prostate | 2 | 2022 | 1765 | 0.430 |
Why?
|
Prostheses and Implants | 4 | 2019 | 1276 | 0.430 |
Why?
|
Particle Accelerators | 4 | 2024 | 173 | 0.430 |
Why?
|
Medulloblastoma | 6 | 2017 | 683 | 0.420 |
Why?
|
Calibration | 5 | 2018 | 819 | 0.420 |
Why?
|
Physics | 3 | 2021 | 92 | 0.410 |
Why?
|
Cerebellar Neoplasms | 5 | 2017 | 591 | 0.410 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.410 |
Why?
|
Chordoma | 5 | 2016 | 349 | 0.400 |
Why?
|
Models, Chemical | 2 | 2016 | 611 | 0.390 |
Why?
|
Spine | 4 | 2017 | 1140 | 0.390 |
Why?
|
Radiation, Ionizing | 4 | 2022 | 252 | 0.370 |
Why?
|
Seminoma | 1 | 2012 | 136 | 0.360 |
Why?
|
DNA Breaks, Double-Stranded | 6 | 2023 | 606 | 0.350 |
Why?
|
Radiation-Sensitizing Agents | 4 | 2016 | 348 | 0.350 |
Why?
|
Carbon | 4 | 2022 | 673 | 0.350 |
Why?
|
Breast Neoplasms | 5 | 2020 | 21206 | 0.340 |
Why?
|
Tumor Burden | 5 | 2018 | 1906 | 0.340 |
Why?
|
Risk Assessment | 11 | 2024 | 24315 | 0.330 |
Why?
|
DNA | 5 | 2022 | 7214 | 0.320 |
Why?
|
Heart | 2 | 2021 | 4446 | 0.320 |
Why?
|
Probability | 5 | 2023 | 2479 | 0.320 |
Why?
|
Nanoparticles | 1 | 2021 | 1985 | 0.320 |
Why?
|
Nasopharyngeal Neoplasms | 5 | 2021 | 290 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2024 | 9015 | 0.310 |
Why?
|
Sensitivity and Specificity | 14 | 2017 | 14729 | 0.310 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2007 | 1232 | 0.310 |
Why?
|
Rectum | 4 | 2017 | 900 | 0.310 |
Why?
|
Fetus | 1 | 2015 | 1883 | 0.300 |
Why?
|
Whole-Body Counting | 1 | 2008 | 36 | 0.300 |
Why?
|
Statistics as Topic | 1 | 2014 | 2357 | 0.300 |
Why?
|
Male | 49 | 2024 | 364719 | 0.300 |
Why?
|
Radioisotopes | 2 | 2023 | 517 | 0.300 |
Why?
|
Alpha Particles | 2 | 2021 | 29 | 0.290 |
Why?
|
Cyclotrons | 2 | 2004 | 30 | 0.280 |
Why?
|
Equipment Design | 5 | 2010 | 3522 | 0.270 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1444 | 0.270 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2830 | 0.260 |
Why?
|
Eye Neoplasms | 4 | 2012 | 306 | 0.260 |
Why?
|
Cricetinae | 6 | 2015 | 2423 | 0.250 |
Why?
|
Testicular Neoplasms | 1 | 2012 | 806 | 0.250 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 721 | 0.240 |
Why?
|
Cell Line | 9 | 2015 | 15597 | 0.240 |
Why?
|
Stochastic Processes | 2 | 2023 | 360 | 0.230 |
Why?
|
Mathematical Concepts | 1 | 2024 | 75 | 0.230 |
Why?
|
Brain | 8 | 2024 | 27360 | 0.230 |
Why?
|
Quality Assurance, Health Care | 3 | 2014 | 2176 | 0.220 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2008 | 879 | 0.220 |
Why?
|
Polyethylene | 2 | 2011 | 187 | 0.220 |
Why?
|
Retrospective Studies | 13 | 2023 | 81762 | 0.220 |
Why?
|
Microspheres | 2 | 2023 | 788 | 0.210 |
Why?
|
Time Factors | 17 | 2024 | 40218 | 0.210 |
Why?
|
Health Care Costs | 1 | 2015 | 3239 | 0.200 |
Why?
|
Clinical Trials as Topic | 4 | 2024 | 8054 | 0.200 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 17140 | 0.200 |
Why?
|
Feasibility Studies | 9 | 2017 | 5315 | 0.200 |
Why?
|
Fibrosarcoma | 1 | 2003 | 313 | 0.190 |
Why?
|
Hemodynamics | 2 | 2023 | 4194 | 0.190 |
Why?
|
Radiography | 5 | 2015 | 6983 | 0.180 |
Why?
|
Hydrogen Peroxide | 1 | 2024 | 740 | 0.180 |
Why?
|
Yttrium Radioisotopes | 1 | 2021 | 115 | 0.180 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2020 | 32 | 0.180 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2018 | 300 | 0.180 |
Why?
|
Female | 31 | 2024 | 397192 | 0.170 |
Why?
|
Organ Specificity | 3 | 2014 | 1968 | 0.170 |
Why?
|
DNA, Neoplasm | 1 | 2005 | 1744 | 0.170 |
Why?
|
Endpoint Determination | 2 | 2020 | 592 | 0.170 |
Why?
|
Child, Preschool | 11 | 2017 | 42669 | 0.170 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 435 | 0.170 |
Why?
|
Workflow | 1 | 2024 | 860 | 0.160 |
Why?
|
Linear Models | 3 | 2016 | 5884 | 0.160 |
Why?
|
Copper | 2 | 2011 | 368 | 0.160 |
Why?
|
Cricetulus | 3 | 2015 | 812 | 0.160 |
Why?
|
Plastics | 2 | 2017 | 119 | 0.160 |
Why?
|
Pulse Radiolysis | 1 | 2018 | 6 | 0.160 |
Why?
|
Biology | 1 | 2021 | 292 | 0.160 |
Why?
|
Bayes Theorem | 2 | 2024 | 2359 | 0.150 |
Why?
|
Cell Growth Processes | 1 | 2019 | 381 | 0.150 |
Why?
|
Child | 15 | 2018 | 80917 | 0.150 |
Why?
|
Animals | 22 | 2024 | 169246 | 0.150 |
Why?
|
Lymphocyte Count | 1 | 2020 | 794 | 0.150 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13676 | 0.140 |
Why?
|
Cell Physiological Phenomena | 1 | 2018 | 152 | 0.140 |
Why?
|
Diagnostic Imaging | 3 | 2021 | 3533 | 0.140 |
Why?
|
Spinal Neoplasms | 3 | 2014 | 715 | 0.140 |
Why?
|
ROC Curve | 1 | 2024 | 3628 | 0.130 |
Why?
|
Knowledge Bases | 1 | 2017 | 97 | 0.130 |
Why?
|
Adolescent | 14 | 2019 | 89169 | 0.130 |
Why?
|
Optic Chiasm | 1 | 2016 | 91 | 0.130 |
Why?
|
Germanium | 1 | 2016 | 7 | 0.130 |
Why?
|
Drug Carriers | 1 | 2021 | 709 | 0.130 |
Why?
|
Adult | 16 | 2024 | 223646 | 0.130 |
Why?
|
Pancreatic Neoplasms | 2 | 2013 | 5446 | 0.130 |
Why?
|
Paclitaxel | 2 | 2021 | 1733 | 0.130 |
Why?
|
Thoracic Wall | 1 | 2018 | 203 | 0.130 |
Why?
|
Age Factors | 6 | 2017 | 18412 | 0.130 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1435 | 0.130 |
Why?
|
Recombinases | 1 | 2016 | 70 | 0.130 |
Why?
|
Infant | 7 | 2017 | 36535 | 0.130 |
Why?
|
Research Report | 1 | 2019 | 369 | 0.130 |
Why?
|
Oxygen Radioisotopes | 1 | 2015 | 75 | 0.120 |
Why?
|
Computer Graphics | 2 | 2019 | 344 | 0.120 |
Why?
|
Normal Distribution | 1 | 2015 | 272 | 0.120 |
Why?
|
Reference Values | 3 | 2015 | 4938 | 0.120 |
Why?
|
Tumor Cells, Cultured | 4 | 2005 | 6124 | 0.120 |
Why?
|
Patient Positioning | 2 | 2014 | 332 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5341 | 0.120 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2015 | 148 | 0.120 |
Why?
|
Body Height | 2 | 2012 | 1565 | 0.110 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2631 | 0.110 |
Why?
|
Cobalt Radioisotopes | 3 | 2016 | 75 | 0.110 |
Why?
|
Pelvic Neoplasms | 1 | 2015 | 250 | 0.110 |
Why?
|
Ions | 3 | 2022 | 255 | 0.110 |
Why?
|
CHO Cells | 3 | 2013 | 1379 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2015 | 269 | 0.110 |
Why?
|
Cytosol | 1 | 2016 | 887 | 0.110 |
Why?
|
Temporal Lobe | 1 | 2021 | 1726 | 0.110 |
Why?
|
Endonucleases | 1 | 2016 | 371 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2023 | 2735 | 0.110 |
Why?
|
Optic Nerve | 1 | 2016 | 571 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 393 | 0.100 |
Why?
|
Optic Nerve Glioma | 1 | 2012 | 32 | 0.100 |
Why?
|
Pelvis | 1 | 2017 | 736 | 0.100 |
Why?
|
Fiducial Markers | 1 | 2013 | 134 | 0.100 |
Why?
|
Urinary Bladder | 2 | 2016 | 1157 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6395 | 0.100 |
Why?
|
Physical Phenomena | 2 | 2018 | 48 | 0.100 |
Why?
|
Breast | 1 | 2020 | 1976 | 0.100 |
Why?
|
Cell Nucleus | 2 | 2020 | 2885 | 0.090 |
Why?
|
Subtraction Technique | 3 | 2009 | 517 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3948 | 0.090 |
Why?
|
Aged | 8 | 2024 | 171504 | 0.090 |
Why?
|
Meningioma | 2 | 2016 | 1220 | 0.090 |
Why?
|
Occupational Exposure | 2 | 2014 | 1807 | 0.090 |
Why?
|
Cohort Studies | 5 | 2018 | 41754 | 0.090 |
Why?
|
Gadolinium | 1 | 2016 | 964 | 0.090 |
Why?
|
Meningeal Neoplasms | 2 | 2016 | 1253 | 0.090 |
Why?
|
Calorimetry | 1 | 2010 | 132 | 0.090 |
Why?
|
Alopecia | 1 | 2014 | 416 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 36743 | 0.090 |
Why?
|
Computers | 1 | 2012 | 592 | 0.090 |
Why?
|
Blood Vessels | 1 | 2015 | 1110 | 0.080 |
Why?
|
Software Validation | 1 | 2009 | 59 | 0.080 |
Why?
|
Liver | 3 | 2022 | 7577 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2232 | 0.080 |
Why?
|
Risk | 3 | 2018 | 9613 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1230 | 0.080 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2008 | 36 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8744 | 0.080 |
Why?
|
Dental Implants | 1 | 2017 | 807 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1155 | 0.080 |
Why?
|
Benchmarking | 2 | 2015 | 1057 | 0.080 |
Why?
|
Body Burden | 1 | 2008 | 158 | 0.070 |
Why?
|
X-Rays | 2 | 2017 | 311 | 0.070 |
Why?
|
Sphenoid Sinus | 1 | 2008 | 101 | 0.070 |
Why?
|
Whole Body Imaging | 1 | 2010 | 284 | 0.070 |
Why?
|
Middle Aged | 10 | 2024 | 223492 | 0.070 |
Why?
|
Neuroectodermal Tumors | 1 | 2007 | 23 | 0.070 |
Why?
|
Spinal Cord | 1 | 2015 | 1811 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 928 | 0.070 |
Why?
|
Nuclear Warfare | 1 | 2007 | 30 | 0.070 |
Why?
|
Thorax | 1 | 2010 | 557 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 1791 | 0.070 |
Why?
|
Mutation | 4 | 2019 | 30238 | 0.070 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1417 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2020 | 1778 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1077 | 0.070 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 265 | 0.070 |
Why?
|
Haplorhini | 1 | 2007 | 523 | 0.070 |
Why?
|
Spinal Cord Neoplasms | 1 | 2008 | 263 | 0.070 |
Why?
|
Magnetics | 1 | 2008 | 597 | 0.060 |
Why?
|
Mice | 8 | 2016 | 82029 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2709 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9419 | 0.060 |
Why?
|
Rad51 Recombinase | 2 | 2016 | 191 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.060 |
Why?
|
Risk Factors | 4 | 2022 | 74944 | 0.060 |
Why?
|
Primates | 1 | 2007 | 520 | 0.060 |
Why?
|
Pituitary Neoplasms | 2 | 2016 | 1322 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2007 | 3390 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5703 | 0.060 |
Why?
|
Lethal Dose 50 | 1 | 2003 | 71 | 0.060 |
Why?
|
Astrocytoma | 1 | 2008 | 774 | 0.060 |
Why?
|
Boron Neutron Capture Therapy | 1 | 2003 | 51 | 0.060 |
Why?
|
Fanconi Anemia | 2 | 2016 | 327 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3681 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 1 | 2002 | 116 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3929 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59629 | 0.050 |
Why?
|
Incidence | 4 | 2018 | 21538 | 0.050 |
Why?
|
Helium | 1 | 2022 | 119 | 0.050 |
Why?
|
Dogs | 1 | 2007 | 3845 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 9092 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4260 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11244 | 0.050 |
Why?
|
Palliative Care | 1 | 2016 | 3643 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3857 | 0.050 |
Why?
|
Body Weight | 1 | 2012 | 4627 | 0.050 |
Why?
|
Swine | 1 | 2011 | 5995 | 0.050 |
Why?
|
Leukemia P388 | 1 | 2000 | 14 | 0.040 |
Why?
|
Fibroblasts | 2 | 2020 | 4176 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.040 |
Why?
|
Visible Human Projects | 1 | 2019 | 12 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2021 | 330 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10760 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2007 | 2363 | 0.040 |
Why?
|
Bone Marrow | 1 | 2010 | 2935 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4978 | 0.040 |
Why?
|
Laboratories | 1 | 2003 | 463 | 0.040 |
Why?
|
Young Adult | 8 | 2021 | 60066 | 0.040 |
Why?
|
Actuarial Analysis | 1 | 2019 | 370 | 0.040 |
Why?
|
Blood Cells | 1 | 2021 | 309 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2000 | 320 | 0.040 |
Why?
|
Cataract Extraction | 1 | 2003 | 464 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10873 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 640 | 0.040 |
Why?
|
Biophysics | 1 | 2000 | 379 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 30010 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9523 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9615 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6526 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39348 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1880 | 0.040 |
Why?
|
Chemical Phenomena | 1 | 2018 | 486 | 0.040 |
Why?
|
Temperature | 1 | 2024 | 2234 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 438 | 0.030 |
Why?
|
Texas | 1 | 2018 | 410 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2846 | 0.030 |
Why?
|
Florida | 1 | 2018 | 417 | 0.030 |
Why?
|
United States | 4 | 2018 | 73039 | 0.030 |
Why?
|
Cesium Radioisotopes | 1 | 2016 | 38 | 0.030 |
Why?
|
Vinblastine | 1 | 2017 | 487 | 0.030 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 211 | 0.030 |
Why?
|
Carboplatin | 1 | 2018 | 797 | 0.030 |
Why?
|
Growth Plate | 1 | 2017 | 276 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 427 | 0.030 |
Why?
|
Biochemical Phenomena | 1 | 2015 | 59 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 2016 | 165 | 0.030 |
Why?
|
Penis | 1 | 2016 | 209 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2016 | 740 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2008 | 2360 | 0.030 |
Why?
|
Teratoma | 1 | 2017 | 405 | 0.030 |
Why?
|
Sex Factors | 1 | 2008 | 10632 | 0.030 |
Why?
|
Rats | 1 | 2010 | 23760 | 0.030 |
Why?
|
Self-Assessment | 1 | 2016 | 400 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2023 | 1402 | 0.030 |
Why?
|
Survival Rate | 1 | 2008 | 12840 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5706 | 0.030 |
Why?
|
Thigh | 1 | 2015 | 238 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30256 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3514 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 899 | 0.030 |
Why?
|
Phthalazines | 1 | 2016 | 397 | 0.030 |
Why?
|
Permeability | 1 | 2015 | 725 | 0.030 |
Why?
|
Neuroma, Acoustic | 1 | 2016 | 455 | 0.030 |
Why?
|
Rotation | 1 | 2014 | 517 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2019 | 1407 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2017 | 2923 | 0.020 |
Why?
|
Automation | 1 | 2014 | 589 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2269 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2012 | 26422 | 0.020 |
Why?
|
Cisplatin | 1 | 2017 | 1660 | 0.020 |
Why?
|
Particle Size | 1 | 2015 | 1649 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 829 | 0.020 |
Why?
|
Thermal Conductivity | 1 | 2010 | 16 | 0.020 |
Why?
|
Esophagus | 1 | 2017 | 1042 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1217 | 0.020 |
Why?
|
Fast Neutrons | 1 | 2010 | 18 | 0.020 |
Why?
|
Thyroid Gland | 1 | 2017 | 1171 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4503 | 0.020 |
Why?
|
Carcinoma | 1 | 2021 | 2332 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 979 | 0.020 |
Why?
|
Air | 1 | 2009 | 187 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4772 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2010 | 287 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2011 | 263 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2601 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2954 | 0.020 |
Why?
|
Sacrum | 1 | 2010 | 274 | 0.020 |
Why?
|
Cerebellum | 1 | 2015 | 1522 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2661 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5403 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2633 | 0.020 |
Why?
|
Adenoma | 1 | 2016 | 2159 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5755 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4755 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3780 | 0.020 |
Why?
|
Cell Communication | 1 | 2012 | 1660 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5902 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2554 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8890 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10474 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6211 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3968 | 0.010 |
Why?
|
Glioblastoma | 1 | 2019 | 3464 | 0.010 |
Why?
|
Bone and Bones | 1 | 2014 | 2589 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3721 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13671 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8509 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 65371 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11878 | 0.010 |
Why?
|